Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway – a national register-based cohort study
2024

Variation in Adjuvant Chemotherapy for Elderly Colon Cancer Patients in Norway

Sample size: 4501 publication Evidence: moderate

Author Information

Author(s): Gustavsen Elin Marthinussen, Norderval Stig, Dørum Liv Marit, Balto Aina, Heimdal Ragnhild, Vonen Barthold, Stensland Eva, Haukland Ellinor, Hauglann Beate

Primary Institution: The Arctic University of Norway (UiT), Tromsø, Norway

Hypothesis

This study investigates socioeconomic and geographic variation in the recommended provision of adjuvant chemotherapy to elderly patients with stage III colon cancer in Norway.

Conclusion

The study found that the provision of adjuvant chemotherapy to elderly stage III colon cancer patients is influenced by socioeconomic status and geographic location, indicating inconsistencies in adherence to treatment guidelines.

Supporting Evidence

  • 13% of patients received adjuvant chemotherapy within 6 weeks after surgery.
  • Odds of receiving chemotherapy decreased with age and frailty.
  • Patients with low socioeconomic status had 33% lower odds of receiving chemotherapy compared to those with high socioeconomic status.
  • Geographic variation in treatment was observed, with odds ratios ranging from 0.41 to 2.58.

Takeaway

Older people with colon cancer sometimes don't get the treatment they need because where they live and how much money they have can affect their care.

Methodology

This population-based retrospective cohort study analyzed data from national registries for patients aged 70 years or older diagnosed with stage III colon cancer between 2011 and 2021 who underwent major surgical resection.

Potential Biases

Potential bias may arise from the underrepresentation of elderly patients in clinical trials and variations in physician recommendations based on patient characteristics.

Limitations

Some cancer staging data was missing, which could introduce selection bias, and the study did not account for patient preferences or cognitive function.

Participant Demographics

Patients aged 70 years or older, with a mean age of 79.0 years; 37% had low frailty scores, 12% had high socioeconomic status, and 59% lived with a cohabitant.

Statistical Information

Confidence Interval

0.50–0.91

Digital Object Identifier (DOI)

10.1007/s43999-024-00057-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication